Arthritis and Autoimmune Diseases Research Center, Rheumatology Section, Department of Medicine, Boston University School of Medicine, Boston MA 02118, United States; Department of Microbiology, Boston University School of Medicine, Boston MA 02118, United States.
Arthritis and Autoimmune Diseases Research Center, Rheumatology Section, Department of Medicine, Boston University School of Medicine, Boston MA 02118, United States.
Cytokine. 2022 Feb;150:155770. doi: 10.1016/j.cyto.2021.155770. Epub 2021 Nov 26.
Signal transducer and activator of transcription 5 (STAT5) plays an important role in regulating gene expression in response to cytokines of the common (γc) chain family. In this capacity, STAT5 promotes CD8 effector and memory T cell survival and regulatory T cell development. However, its function in conventional CD4 T cells is less clear. In this study, the requirement of intact STAT5 signaling for CD4 effector and memory T cell generation and maintenance was investigated by using DO11.10 TCR transgenic T cells that are genetically deficient in STAT5A or B, as well as by transducing DO11 T cells with a dominant-negative STAT5 to temporally block STAT5 function. We found that the presence of STAT5A or B alone was sufficient for primary CD4 effector T cell generation, but not for establishing a long-lived memory cell population. Similarly, blocking STAT5 signaling during priming did not prevent initial T cell activation, but inhibited the generation of memory cells. Surprisingly, blocking STAT5 post-priming did not impact the long-term survival of CD4 memory T cells in vivo. Mechanistically, intact STAT5B, but not STAT5A, was required for IL-7Rα re-expression in activated T cells, which is an important cytokine receptor for CD4 memory generation. These data show that fully functional STAT5 is essential to deliver an early, non-redundant signal for memory programming during the primary CD4 T cell response, while partial STAT5 signaling is sufficient for effector differentiation. Our results have implications for the precise use of STAT5 inhibitors to timely inhibit memory T cell responses.
信号转导子和转录激活子 5(STAT5)在调节细胞因子共同(γc)链家族的基因表达中发挥重要作用。在这种能力中,STAT5 促进 CD8 效应器和记忆 T 细胞的存活和调节性 T 细胞的发育。然而,其在常规 CD4 T 细胞中的功能尚不清楚。在这项研究中,通过使用 DO11.10 TCR 转基因 T 细胞,该细胞在 STAT5A 或 B 中存在遗传缺陷,以及通过转导 DO11 细胞具有显性负 STAT5 以暂时阻断 STAT5 功能,研究了完整 STAT5 信号对 CD4 效应器和记忆 T 细胞生成和维持的要求。我们发现,单独存在 STAT5A 或 B 足以产生原发性 CD4 效应 T 细胞,但不足以建立长寿的记忆细胞群体。同样,在启动过程中阻断 STAT5 信号不会阻止初始 T 细胞激活,但会抑制记忆细胞的生成。令人惊讶的是,在启动后阻断 STAT5 信号不会影响体内 CD4 记忆 T 细胞的长期存活。从机制上讲,完整的 STAT5B,但不是 STAT5A,是在激活的 T 细胞中重新表达 IL-7Rα 所必需的,这是 CD4 记忆生成的重要细胞因子受体。这些数据表明,完全功能的 STAT5 对于在原发性 CD4 T 细胞反应期间传递记忆编程的早期、非冗余信号是必不可少的,而部分 STAT5 信号足以进行效应器分化。我们的结果对精确使用 STAT5 抑制剂及时抑制记忆 T 细胞反应具有重要意义。